Pls refer the attachment

Mgmt Guided Margin ImprovementAnalyst Day Multiyear TargetsInvestor Communications View source PDF

VIJAYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+10.1%1-day move

₹1208.00

prior close

₹1269.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-2.4-2.7-2.5-2.9+10.1+6.0+7.0+6.0+11.3+8.0+3.4+8.1+10.1—

Up moveDown movePending

AI summary

Vijaya Diagnostic reported strong Q4 & FY26 results with revenues crossing INR 800 Cr for the first time. Q4 FY26 revenue grew 26.6% YoY to INR 2,194 Mn with EBITDA margin at 43.5% (up from 39.8% in Q4 FY25) and PAT margin at 21.8%. Full year FY26 revenue was INR 8,142 Mn (19.5% growth), with EBITDA of INR 3,369 Mn (41.4% margin) and PAT of INR 1,730 Mn (21.2% margin). The company achieved 16.5% CAGR over 5 years since listing, outperforming its 15% guidance. Management noted that EBITDA margins remained ahead of their 40% guidance. Operations expanded to 162 centres serving 4.68 Mn footfalls and 16.92 Mn tests during FY26.

Likely market impact

Strong quarterly and annual performance with margin expansion demonstrates operational efficiency gains. The company has guided for continued hub expansion (4-5 hubs, 10-12 spokes in FY27) and is setting up an automated lab to improve turnaround times, which should support sustained growth.